Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03505184
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.71 | |
CCL | N~6~-[(CYCLOPENTYLOXY)CARBONYL]- D-LYSINE | A | 2Q7G | 0.71 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.79 | |
H5M | TRANS-3-HYDROXY-5-METHYLPROLINE | A,B | 1A7Z | 0.71 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.75 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.71 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.71 | |
OLN | (S)-2-ACETAMIDO-5-UREIDOPENTANOIC ACID | A | 1YH1 | 0.7 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CAY | 0.73 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CBA | 0.73 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.75 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.77 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W03 | 0.7 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W04 | 0.7 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.8 | |
VB1 | N^6^-[(1R)-2-{[(1S)-1-carboxypropyl]amino}- 2-oxo-1-(sulfanylmethyl)ethyl]- 6-oxo-L-lysine | A | 2VBP | 0.72 | |
EP2 | methyl N-[(2S)-4-{[(1S)-1-{[(2S)- 2-carboxypyrrolidin-1-yl]carbonyl}- 3-methylbutyl]amino}-2-hydroxy- 4-oxobutanoyl]-L-leucylglycylglycinate | B | 1SP4 | 0.74 | |
SSC | (2S,5S)-5-CARBOXYMETHYLPROLINE | A,B,C,D | 1Q19 | 0.71 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W05 | 0.72 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W06 | 0.72 | |
74M | METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN- 2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | A | 2DC9 | 0.71 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.72 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.71 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.78 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.7 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.7 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.7 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.7 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.7 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.7 | |
SUJ | (2R,3R)-2-[(3S,6R)-3-AMINO-6-HYDROXY- 2-OXOPIPERIDINYL]-3-HYDROXYBUTANOIC ACID | C,D | 1OKX | 0.75 | |
FEB | N~2~-[(3R)-3-hydroxydodecanoyl]- L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)- 3-methylbutyl]-L-glutamamide | 2,H,K,N,V,Y | 3D29 | 0.74 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.72 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.72 | |
HJ3 | (2R,4S)-2-[(1R)-1-{[(6S)-6-amino- 6-carboxyhexanoyl]amino}-2-oxoethyl]- 5,5-dimethyl-1,3-thiazolidine-4- carboxylic acid | A | 3BEB | 0.73 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.76 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.76 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.74 | |
ECQ | (3S)-3-[(2S)-2-AMINO-3-HYDROXYBUTYL]PYRROLIDIN- 2-ONE | A,I | 2Z3D | 0.72 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.73 | |
NAY | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 2-OXONONANOIC ACID | A,C | 1F74 | 0.72 | |
BB2 | ACTINONIN | A,B,C,D | 3G5K | 0.73 | |
BB2 | ACTINONIN | A,B,C | 1LRU | 0.73 | |
BB2 | ACTINONIN | A,B | 2OKL | 0.73 | |
BB2 | ACTINONIN | A | 2OS1 | 0.73 | |
BB2 | ACTINONIN | A,B,C | 1G2A | 0.73 | |
BB2 | ACTINONIN | A | 1Q1Y | 0.73 | |
BB2 | ACTINONIN | A,B,C,D,E,F, G,H | 1SZZ | 0.73 | |
BB2 | ACTINONIN | A | 1LQY | 0.73 | |
BB2 | ACTINONIN | A | 2OS3 | 0.73 | |
BB2 | ACTINONIN | A | 1LRY | 0.73 | |
BB2 | ACTINONIN | A,B | 1IX1 | 0.73 | |
BB2 | ACTINONIN | A | 1WS1 | 0.73 | |
NEG | NEGAMYCIN | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 2QEX | 0.7 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.71 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.79 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWJ | 0.77 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWG | 0.77 | |
PCV | 5-AMINO-3-HYDROXY-2-(2-OXO-AZETIDIN- 1-YL)-PENTANOIC ACID | A | 1DRT | 0.72 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.8 |